Physician

Tristan Chawn Bice, MD

According to 2025 Medicare claims, Tristan Bice, MD (NPI: 1912369190) practices hematology/oncology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Clark, WA. This provider's primary affiliated billing organization is NORTHWEST CANCER SPECIALISTS PC (NPI: 1407828114; TIN: 931280206) and primary practice location at 98684-6930.

Bice's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 409 traditional Medicare patients, billed 98,986 HCPCS/CPT codes, and received $1,398,184 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,067 prescription claims across 143 beneficiaries totaling $2,861,709 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 54 claims. Open Payments data shows 23 records totaling $49,598. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,506 to $2,861,709. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$699K$1.4M2022 Medicare payment: $400,609 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,340,007 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,398,184 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202216222,494$400,609
202340481,784$1,340,007
202440998,986$1,398,184

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.9M2017 Drug cost: $3,506 (USD; Tot_Drug_Cst)2018 Drug cost: $13,326 (USD; Tot_Drug_Cst)2019 Drug cost: $54,183 (USD; Tot_Drug_Cst)2020 Drug cost: $10,309 (USD; Tot_Drug_Cst)2021 Drug cost: $230 (USD; Tot_Drug_Cst)2022 Drug cost: $55,441 (USD; Tot_Drug_Cst)2023 Drug cost: $1,616,268 (USD; Tot_Drug_Cst)2024 Drug cost: $2,861,709 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171839$3,506
201848207$13,326
201947511$54,183
202023173$10,309
2021N/R34$230
20222154$55,441
2023119705$1,616,268
20241431,067$2,861,709

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$516$1.0K2023 Medicare payment: $647 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,031 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R15$647
2024N/R54$1,031

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more105237$93
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's90192$12
80053Blood test, comprehensive group of blood chemicals123417$10
36415Insertion of needle into vein for collection of blood sample130392$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count128479$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CalquenceAcalabrutinib Maleate521,560$713,651
TasignaNilotinib Hcl13364$250,118
WeliregBelzutifan12360$242,036
VenclextaVenetoclax16480$236,879
Abiraterone AcetateAbiraterone Acetate1685,280$218,845

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8700Temozolomide, oral, 5 mgNN/R27$649
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R12$207
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R15$176

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$764Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.13$48,834Janssen Research & Development, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tristan Chawn Bice, MD?

Tedicare shows public-source Medicare data for Tristan Chawn Bice, MD (NPI 1912369190), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tristan Chawn Bice, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tristan Chawn Bice, MD?

Tristan Chawn Bice, MD is linked to NORTHWEST CANCER SPECIALISTS PC (billing NPI 1407828114) in the available physician profile data.

Does Tristan Chawn Bice, MD have Open Payments data?

Tristan Chawn Bice, MD has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.